Tycho Peterson
Stock Analyst at Jefferies
(5.00)
# 1
Out of 4,996 analysts
131
Total ratings
65.22%
Success rate
164.64%
Average return
Main Sectors:
Stocks Rated by Tycho Peterson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Buy | $435 → $385 | $291.71 | +31.98% | 8 | Aug 4, 2025 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $155 | $123.39 | +25.62% | 8 | May 29, 2025 | |
| WGS GeneDx Holdings | Upgrades: Buy | $80 | $117.21 | -31.75% | 1 | May 9, 2025 | |
| QDEL QuidelOrtho | Upgrades: Buy | $44 | $28.33 | +55.31% | 6 | May 8, 2025 | |
| MTD Mettler-Toledo International | Upgrades: Hold | $1,200 → $1,100 | $1,204.43 | -8.67% | 8 | May 5, 2025 | |
| DHR Danaher | Maintains: Overweight | $280 → $260 | $184.84 | +40.66% | 3 | Apr 22, 2025 | |
| LH Labcorp Holdings | Maintains: Buy | $275 → $290 | $280.61 | +3.35% | 2 | Feb 6, 2025 | |
| NEO NeoGenomics | Initiates: Buy | $22 | $7.93 | +177.43% | 1 | Dec 10, 2024 | |
| DGX Quest Diagnostics | Assumes: Buy | $185 | $188.99 | -2.11% | 1 | Dec 10, 2024 | |
| HOLX Hologic | Initiates: Hold | $85 | $67.21 | +26.47% | 7 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $43 → $56 | $43.90 | +26.70% | 5 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $35 | $26.91 | +30.06% | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $115 → $125 | $84.06 | +48.70% | 1 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $24 | $11.72 | +104.78% | 7 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $1.21 | +230.58% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $5 → $3 | $0.83 | +262.84% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $142 | $162.97 | -12.87% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $60.03 | -46.69% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $115 | $91.69 | +25.42% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Underperform | $25 → $20 | $7.70 | +159.74% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $600 → $650 | $464.24 | +40.01% | 12 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $26 → $9 | $15.82 | -43.11% | 1 | Sep 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.27 | - | 2 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 → $12 | $2.27 | +428.63% | 2 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $60 | $5.19 | +1,056.07% | 2 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $23 | $4.13 | +456.90% | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $375 → $390 | $148.56 | +162.52% | 5 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $3.20 | +462.50% | 1 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $188 → $200 | $441.12 | -54.66% | 9 | Jun 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $24 | $20.35 | +17.94% | 3 | Jun 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $65 → $45 | $12.50 | +260.00% | 5 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $60 → $70 | $125.61 | -44.27% | 2 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $120 | $179.56 | -33.17% | 1 | Feb 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $1.67 | - | 7 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $31.04 | - | 5 | Nov 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $55 | $13.85 | +297.11% | 1 | Jul 19, 2016 |
Waters
Aug 4, 2025
Maintains: Buy
Price Target: $435 → $385
Current: $291.71
Upside: +31.98%
Agilent Technologies
May 29, 2025
Maintains: Overweight
Price Target: $160 → $155
Current: $123.39
Upside: +25.62%
GeneDx Holdings
May 9, 2025
Upgrades: Buy
Price Target: $80
Current: $117.21
Upside: -31.75%
QuidelOrtho
May 8, 2025
Upgrades: Buy
Price Target: $44
Current: $28.33
Upside: +55.31%
Mettler-Toledo International
May 5, 2025
Upgrades: Hold
Price Target: $1,200 → $1,100
Current: $1,204.43
Upside: -8.67%
Danaher
Apr 22, 2025
Maintains: Overweight
Price Target: $280 → $260
Current: $184.84
Upside: +40.66%
Labcorp Holdings
Feb 6, 2025
Maintains: Buy
Price Target: $275 → $290
Current: $280.61
Upside: +3.35%
NeoGenomics
Dec 10, 2024
Initiates: Buy
Price Target: $22
Current: $7.93
Upside: +177.43%
Quest Diagnostics
Dec 10, 2024
Assumes: Buy
Price Target: $185
Current: $188.99
Upside: -2.11%
Hologic
Dec 10, 2024
Initiates: Hold
Price Target: $85
Current: $67.21
Upside: +26.47%
Dec 10, 2024
Assumes: Buy
Price Target: $43 → $56
Current: $43.90
Upside: +26.70%
Aug 5, 2024
Maintains: Underweight
Price Target: $28 → $35
Current: $26.91
Upside: +30.06%
Jul 29, 2024
Maintains: Hold
Price Target: $115 → $125
Current: $84.06
Upside: +48.70%
Jul 22, 2024
Upgrades: Buy
Price Target: $24
Current: $11.72
Upside: +104.78%
Jun 3, 2024
Initiates: Buy
Price Target: $4
Current: $1.21
Upside: +230.58%
Jun 3, 2024
Assumes: Hold
Price Target: $5 → $3
Current: $0.83
Upside: +262.84%
Jun 3, 2024
Initiates: Buy
Price Target: $142
Current: $162.97
Upside: -12.87%
Jun 3, 2024
Initiates: Buy
Price Target: $32
Current: $60.03
Upside: -46.69%
Jun 3, 2024
Assumes: Hold
Price Target: $115
Current: $91.69
Upside: +25.42%
Jun 3, 2024
Assumes: Underperform
Price Target: $25 → $20
Current: $7.70
Upside: +159.74%
Jun 3, 2024
Assumes: Buy
Price Target: $600 → $650
Current: $464.24
Upside: +40.01%
Sep 21, 2022
Downgrades: Underweight
Price Target: $26 → $9
Current: $15.82
Upside: -43.11%
Aug 16, 2022
Downgrades: Neutral
Price Target: n/a
Current: $3.27
Upside: -
Aug 11, 2022
Downgrades: Neutral
Price Target: $20 → $12
Current: $2.27
Upside: +428.63%
Mar 2, 2022
Maintains: Overweight
Price Target: $85 → $60
Current: $5.19
Upside: +1,056.07%
Aug 17, 2021
Initiates: Overweight
Price Target: $23
Current: $4.13
Upside: +456.90%
May 28, 2021
Maintains: Overweight
Price Target: $375 → $390
Current: $148.56
Upside: +162.52%
Aug 10, 2020
Initiates: Neutral
Price Target: $18
Current: $3.20
Upside: +462.50%
Jun 18, 2020
Maintains: Overweight
Price Target: $188 → $200
Current: $441.12
Upside: -54.66%
Jun 1, 2020
Maintains: Overweight
Price Target: $22 → $24
Current: $20.35
Upside: +17.94%
Mar 17, 2020
Maintains: Neutral
Price Target: $65 → $45
Current: $12.50
Upside: +260.00%
Nov 2, 2018
Maintains: Overweight
Price Target: $60 → $70
Current: $125.61
Upside: -44.27%
Feb 15, 2018
Maintains: Overweight
Price Target: $115 → $120
Current: $179.56
Upside: -33.17%
Dec 13, 2017
Downgrades: Underweight
Price Target: n/a
Current: $1.67
Upside: -
Nov 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $31.04
Upside: -
Jul 19, 2016
Initiates: Neutral
Price Target: $55
Current: $13.85
Upside: +297.11%